These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 15995033
1. Effect of nutrition on growth in short stature before and during growth-hormone therapy. Zadik Z, Sinai T, Zung A, Reifen R. Pediatrics; 2005 Jul; 116(1):68-72. PubMed ID: 15995033 [Abstract] [Full Text] [Related]
2. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children? Lanes R, Jakubowicz S. J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186 [Abstract] [Full Text] [Related]
12. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884 [Abstract] [Full Text] [Related]
13. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children? de Kort SW, Willemsen RH, van der Kaay DC, Duivenvoorden HJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725 [Abstract] [Full Text] [Related]
14. Regular fluctuations in growth hormone (GH) release determine normal human growth. Gill MS, Thalange NK, Foster PJ, Tillmann V, Price DA, Diggle PJ, Clayton PE. Growth Horm IGF Res; 1999 Apr; 9(2):114-22. PubMed ID: 10373344 [Abstract] [Full Text] [Related]
16. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes. Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ. Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412 [Abstract] [Full Text] [Related]
17. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board. Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957 [Abstract] [Full Text] [Related]
19. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG. Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903 [Abstract] [Full Text] [Related]
20. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature. Gascoin-Lachambre G, Trivin C, Brauner R, Souberbielle JC. Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]